{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-088165","form_type":"8-K/A","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2026-08-12T15:50:09+00:00","discovered_at":"2026-08-12T15:51:00.405888+00:00","generated_at":"2026-08-12T15:51:06.485561+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"ABVC BioPharma postpones BioKey share distribution to Aug 21, 2026","bullets":["Distribution of BioKey (Cayman) ordinary shares moved from Aug 3 to Aug 21, 2026.","Record date remains July 24, 2026; ratio unchanged at 0.169464 BioKey shares per ABVC share.","Ex-dividend date will be revised and announced after administrative, regulatory, and tax matters are completed.","Company coordinated with Nasdaq, DTC, and transfer agent on revised distribution mechanics."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-088165","json":"https://secwatch.observer/filing/0001213900-26-088165.json","markdown":"https://secwatch.observer/filing/0001213900-26-088165.md","text":"https://secwatch.observer/filing/0001213900-26-088165.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026088165/0001213900-26-088165-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026088165/ea0301755-8ka1_abvc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-12T15:51:06.485561+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}